Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079281 | SCV000111151 | uncertain significance | not provided | 2012-09-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084502 | SCV000259926 | likely benign | Long QT syndrome | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621900 | SCV000737406 | likely benign | Cardiovascular phenotype | 2016-12-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV001256728 | SCV001433134 | benign | not specified | 2019-11-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000079281 | SCV001885799 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000079281 | SCV004129714 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | CACNA1C: BP4, BS2 |